Marco Benasso

10.7k total citations · 1 hit paper
67 papers, 3.7k citations indexed

About

Marco Benasso is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Marco Benasso has authored 67 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Otorhinolaryngology, 33 papers in Pulmonary and Respiratory Medicine and 33 papers in Oncology. Recurrent topics in Marco Benasso's work include Head and Neck Cancer Studies (49 papers), Head and Neck Surgical Oncology (16 papers) and Lung Cancer Treatments and Mutations (14 papers). Marco Benasso is often cited by papers focused on Head and Neck Cancer Studies (49 papers), Head and Neck Surgical Oncology (16 papers) and Lung Cancer Treatments and Mutations (14 papers). Marco Benasso collaborates with scholars based in Italy, United Kingdom and United States. Marco Benasso's co-authors include Ricardo Hitt, Andrzej Kawecki, Sylvie Rottey, Ricard Mesı́a, Éva Remenár, D. De Raucourt, Didier Cupissol, Carsten Bokemeyer, Fernando Rivera and Armin Schueler and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Marco Benasso

61 papers receiving 3.6k citations

Hit Papers

Platinum-Based Chemotherapy plus Cetuximab in Head and Ne... 2008 2026 2014 2020 2008 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
    2008 2.6k citations Marco Benasso et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Benasso Italy 16 2.1k 2.0k 1.6k 1.2k 759 67 3.7k
Armin Schueler Germany 11 1.8k 0.8× 2.2k 1.1× 1.6k 1.0× 962 0.8× 962 1.3× 18 3.8k
D. De Raucourt France 22 2.8k 1.3× 2.2k 1.1× 1.9k 1.1× 1.9k 1.5× 787 1.0× 55 4.4k
Andrzej Kawecki Poland 11 1.6k 0.8× 1.8k 0.9× 1.4k 0.8× 923 0.8× 717 0.9× 46 3.1k
Roger Ove United States 11 1.7k 0.8× 2.0k 1.0× 1.7k 1.1× 1.1k 0.9× 978 1.3× 36 4.1k
Éva Remenár Hungary 21 2.9k 1.4× 2.7k 1.3× 2.0k 1.2× 1.8k 1.5× 1.1k 1.4× 64 5.0k
József Erfán Hungary 5 1.4k 0.7× 1.5k 0.8× 1.2k 0.7× 769 0.6× 614 0.8× 6 2.6k
C. Chao United States 18 2.4k 1.1× 975 0.5× 1.3k 0.8× 1.7k 1.4× 444 0.6× 39 3.5k
Hyunseok Kang United States 28 1.0k 0.5× 2.0k 1.0× 889 0.5× 1000 0.8× 772 1.0× 102 3.4k
Ricardo Hitt Spain 28 3.5k 1.6× 4.0k 2.0× 2.9k 1.8× 2.0k 1.6× 1.5k 1.9× 69 6.7k
Antonio López–Pousa Spain 32 771 0.4× 1.7k 0.8× 1.9k 1.1× 804 0.7× 541 0.7× 161 3.4k

Countries citing papers authored by Marco Benasso

Since Specialization
Citations

This map shows the geographic impact of Marco Benasso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Benasso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Benasso more than expected).

Fields of papers citing papers by Marco Benasso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Benasso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Benasso. The network helps show where Marco Benasso may publish in the future.

Co-authorship network of co-authors of Marco Benasso

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Benasso. A scholar is included among the top collaborators of Marco Benasso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Benasso. Marco Benasso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Merlano, Marco, Nerina Denaro, Marco Benasso, et al.. (2019). Difficulties in conducting pure academic research, obstacles in data collection and quality of informations: The example of the INTERCEPTOR study. Oral Oncology. 97. 99–104. 3 indexed citations
2.
Blondeaux, Eva, Maurizio Cantore, Andrea Michelotti, et al.. (2019). Dose-dense adjuvant chemotherapy in early breast cancer: 15–year results of the phase III Mammella InterGruppo (MIG)-1 study. Annals of Oncology. 30. iii27–iii27. 1 indexed citations
3.
Giraudi, S., Andrea Michelotti, Andrea De Censi, et al.. (2016). Dose-dence adjuvant chemotherapy in early breast cancer: the results of 15 years of follow-up. Annals of Oncology. 27. iv61–iv61. 1 indexed citations
4.
Russi, Elvio, Francesco Moretto, Monica Rampino, et al.. (2015). Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus. Critical Reviews in Oncology/Hematology. 96(1). 167–182. 45 indexed citations
5.
Benasso, Marco. (2013). Induction chemotherapy for squamous cell head and neck cancer: A neverending story?. Oral Oncology. 49(8). 747–752. 14 indexed citations
6.
Russi, Elvio, Marco Merlano, Gianmauro Numico, et al.. (2011). The effects on pain and activity of daily living caused by crusted exudation in patients with head and neck cancer treated with cetuximab and radiotherapy. Supportive Care in Cancer. 20(9). 2141–2147. 8 indexed citations
7.
Merlano, Marco, Elvio Russi, Marco Benasso, et al.. (2010). Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study. Annals of Oncology. 22(3). 712–717. 60 indexed citations
8.
Benasso, Marco, Marco Merlano, Gianmauro Numico, et al.. (2006). Paclitaxel, cisplatin and 5-fluorouracil in recurrent squamous cell carcinoma of the head and neck: A phase II trial from an Italian cooperative group. Acta Oncologica. 45(2). 168–174. 12 indexed citations
9.
Benasso, Marco, Renzo Corvò, Giuseppe Sanguineti, et al.. (2004). Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck. Annals of Oncology. 15(4). 646–652. 25 indexed citations
10.
Corvò, Renzo, Marco Benasso, Giuseppe Sanguineti, et al.. (2001). Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck The following oncologists partcipated in this randomized study: Paolo Bruzzi, M.D., Isabella Ricci, M.D., Katia Donato, M.D., Franca Foppiano, Ph.D. (Istituto Nazionale per la Ricerca sul Cancro, Genova); Alida Santelli, M.D., Filippo Borasi, M.D. (Divisione of Otorinolaringoiatria–Ospedale San Martino, Genova); Enzo Mora, M.D., Marco Barbieri, M.D. (Clinica Otorinolaringoiatrica-Universita, Genova); Corrado Marziano, M.D., Renato Chiarlone, M.D., Fulvio Brema, M.D. (Ospedale S. Paolo, Savona); Giovanni Ricci, M.D., Andrea Grimaldi, M.D., Monica Cavallari, M.D. (Ospedale Galliera, Genova); Giammauro Numico, M.D. (Ospedale S. Croce e Carle, Cuneo, Italy).. Cancer. 92(11). 2856–2856. 2 indexed citations
11.
Benasso, Marco, Giuseppe Sanguineti, Rita Lionetto, et al.. (2001). Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck. Cancer. 92(11). 2856–2867. 48 indexed citations
12.
Corvò, Renzo, et al.. (2001). New chemoradiotherapy combinations in head and neck cancer. Expert Review of Anticancer Therapy. 1(1). 111–115. 3 indexed citations
13.
Corvò, Renzo, G. Paoli, Walter Giaretti, et al.. (2000). Evidence of cell kinetics as predictive factor of response to radiotherapy alone or chemoradiotherapy in patients with advanced head and neck cancer. International Journal of Radiation Oncology*Biology*Physics. 47(1). 57–63. 15 indexed citations
14.
Benasso, Marco, Giuseppe Sanguineti, Michele D’Amico, et al.. (2000). Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma. British Journal of Cancer. 83(11). 1437–1442. 9 indexed citations
15.
Sanguineti, Giuseppe, Renzo Corvò, Maria Pia Sormani, et al.. (1999). Chemotherapy alternated with radiotherapy in the treatment of advanced head and neck carcinoma: predictive factors of outcome. International Journal of Radiation Oncology*Biology*Physics. 44(1). 139–147. 7 indexed citations
16.
Merlano, Marco, Marco Benasso, Gianmauro Numico, et al.. (1998). 5-Fluorouracil Dose Intensification and Granulocyte-Macrophage Colony-Stimulating Factor in Cisplatin-Based Chemotherapy for Relapsed Squamous Cell Carcinoma of the Head and Neck. American Journal of Clinical Oncology. 21(3). 313–316. 2 indexed citations
17.
18.
Merlano, Marco, Marco Benasso, Renzo Corvò, et al.. (1996). Five-Year Update of a Randomized Trial of Alternating Radiotherapy and Chemotherapy Compared With Radiotherapy Alone in Treatment of Unresectable Squamous Cell Carcinoma of the Head and Neck. JNCI Journal of the National Cancer Institute. 88(9). 583–589. 190 indexed citations
19.
Merlano, Marco, R. Rosso, M. R. Sertoli, et al.. (1988). Sequential versus alternating chemotherapy and radiotherapy in stage III-IV squamous cell carcinoma of the head and neck: a phase III study.. Journal of Clinical Oncology. 6(4). 627–632. 32 indexed citations
20.
Merlano, Marco, et al.. (1986). Topical administration of cisplatin in far-advanced squamous cell carcinoma of the head and neck. European Journal of Cancer and Clinical Oncology. 22(1). 119–120. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Armin Schueler Breakdown of academic impact, for papers by D. De Raucourt Breakdown of academic impact, for papers by Andrzej Kawecki Breakdown of academic impact, for papers by Roger Ove Breakdown of academic impact, for papers by Éva Remenár Breakdown of academic impact, for papers by József Erfán Breakdown of academic impact, for papers by C. Chao Breakdown of academic impact, for papers by Hyunseok Kang Breakdown of academic impact, for papers by Ricardo Hitt Breakdown of academic impact, for papers by Antonio López–Pousa
Rankless by CCL
2026